Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Gastroenterologist
M.B.B.S., F.C.P.S ( Gastroenterologist )
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Rheumatologist
MBBS, FCPS (Medicine), Fellowship in Rheumatology
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Rheumatologist
MBBS, FCPS (Medicine), Fellowship in Rheumatology
Diabetologist
MBBS, Post Graduate Diploma In Diabetes (DIP)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures